Progress and Challenges in Scaling Up Laboratory Monitoring of HIV Treatment

Peter H Kilmarx, Raiva Simbi, Peter H Kilmarx, Raiva Simbi

Abstract

In a perspective on Habiyambere and colleagues, Peter Kilmarx and Raiva Simbi discuss the disconnect between HIV testing instrument capacity and utilization.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. UNAIDS. Ambitious treatment targets: writing the final chapter of the AIDS epidemic. Geneva, 2015.
    1. UNAIDS. AIDS Update 2016, Geneva, 2016.
    1. Alemnji G, Fonjungo P, Van Der Pol B, Peter T, Kantor R, Nkengasong J. The centrality of laboratory services in the HIV treatment and prevention cascade: The need for effective linkages and referrals in resource-limited settings. AIDS Patient Care STDS. 2014;28(5):268–273. 10.1089/apc.2013.0356
    1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva, 2013.
    1. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva, 2015.
    1. Habiyambere V, Ford N, Low-Beer D, Nkengasong J, Sands A, Pérez González M, et al. (2016) Availability and use of HIV monitoring and early infant diagnosis technologies in WHO member states in 2011–2013: analysis of annual surveys at the facility level. PLoS Med 13(8): e1002088 10.1371/journal.pmed.1002088
    1. World Health Organization. Technical and operational considerations for implementing HIV viral load testing: interim technical update. Geneva, 2014.
    1. Vian T. Review of corruption in the health sector: theory, methods and interventions. Health Policy Plan. 2008. March;23(2):83–94. 10.1093/heapol/czm048
    1. Transparency International. Curbing Corruption in Public Procurement: A Practical Guide. Germany, 2014. .
    1. Haas AD, Keiser O, Balestre E, et al.; IeDEA southern Africa, east Africa, and west Africa. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Lancet HIV. 2015;2(7):e271–278. 10.1016/S2352-3018(15)00087-9
    1. UNAIDS. On the Fast-Track to an AIDS-free generation. Geneva, 2016.
    1. Yao K, Maruta T, Luman ET, Nkengasong JN. The SLMTA programme: Transforming the laboratory landscape in developing countries. Afr J Lab Med. 2014;3(2)194.
    1. Kilmarx PH, Mutasa-Apollo T. Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS. 2013;8(1):59–64. 10.1097/COH.0b013e32835b806e
    1. Ministry of Health and Child Care. Zimbabwe HIV Viral Load Scale-up Plan 2015–2018. Harare, 2015.
    1. World Health Organization. HIV drug resistance surveillance guidance—2015 update. Geneva, 2015.

Source: PubMed

3
Abonnere